IMPAX LABORATORIES INC (IPXL) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:IPXL • US45256B1017

18.3
0 (0%)
At close: May 4, 2018
18.3
0 (0%)
After Hours: 5/4/2018, 8:32:37 PM
No Fundamental Analysis report for IPXL not available.

IMPAX LABORATORIES INC

NASDAQ:IPXL (5/4/2018, 8:32:37 PM)

After market: 18.3 0 (0%)

18.3

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners90.41%
Inst Owner ChangeN/A
Ins Owners0.86%
Ins Owner Change0%
Market Cap1.35B
Revenue(TTM)775.79M
Net Income(TTM)-469.29M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)0%
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 29.05
Fwd PE 15.38
P/S 1.74
P/FCF N/A
P/OCF N/A
P/B 7.22
P/tB N/A
EV/EBITDA -6.68
EPS(TTM)0.63
EY3.44%
EPS(NY)1.19
Fwd EY6.5%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.5
BVpS2.53
TBVpSN/A
PEG (NY)0.33
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -34.73%
ROE -250.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) -60.49%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 4.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.96
Quick Ratio 1.52
Altman-Z -0.04
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-45.69%
EPS 3YN/A
EPS 5Y-6.38%
EPS Q2Q%-31.25%
EPS Next Y88.89%
EPS Next 2Y59.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.9%
Revenue growth 3YN/A
Revenue growth 5Y5.93%
Sales Q2Q%-7.82%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

IMPAX LABORATORIES INC / IPXL FAQ

What is the ChartMill fundamental rating of IMPAX LABORATORIES INC (IPXL) stock?

ChartMill assigns a fundamental rating of 3 / 10 to IPXL.


What is the valuation status for IPXL stock?

ChartMill assigns a valuation rating of 4 / 10 to IMPAX LABORATORIES INC (IPXL). This can be considered as Fairly Valued.


Can you provide the profitability details for IMPAX LABORATORIES INC?

IMPAX LABORATORIES INC (IPXL) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for IPXL stock?

The Price/Earnings (PE) ratio for IMPAX LABORATORIES INC (IPXL) is 29.05 and the Price/Book (PB) ratio is 7.22.


Can you provide the financial health for IPXL stock?

The financial health rating of IMPAX LABORATORIES INC (IPXL) is 2 / 10.